Do I qualify?

Do I qualify for this study?

  • Do you have Peripheral Arterial Disease (PAD)?
  • Do you have a sore on your leg, ankle, or foot that will not heal?
  • Have you been diagnosed with Critical Limb Ischemia?
Qualify for participation in Lifecell's Stem Cell study
Sign-up for this clinical study

You may qualify to participate in this clinical study of an investigational treatment if you suffer from Critical Limb Ischemia and have been told by a physician that you are no longer a candidate for surgical or other interventional treatment.

This study seeks to determine if treatment with adult stem cells, taken from the patient’s own bone marrow, can improve healing and prevent amputation.

To qualify to participate, you must be between 18-80 years old with established CLI (Rutherford Category 4 to 5 per the recommendations of the TASC) with angiographic evidence of significant infra-inguinal arterial occlusive disease with no surgical or interventional options for revascularization and no response to optimal medical care as confirmed by a vascular surgeon and/or physician.

Screening period of approximately 7-14 days, study intervention requires about 24 hrs of hospitalization for bone marrow extraction and administration of ASCT01/placebo. Study follow-up is for 12 months at specified intervals, with assessment of study endpoints at day 90.

You may also view more complete information about this study (IND 15069) on, a registry of clinical trials conducted in the United States and around the world.

Sign-up for this clinical study

For additional information or questions about this study, please use the information below to contact us.

Kansas City Vascular Foundation (KCV).

Rebecca Thomas, CVRN - BC 816-842-5555 Ext. 1605 This email address is being protected from spambots. You need JavaScript enabled to view it. 

Investigator: Karl R Stark, MD

Contact Us       |        See if You Qualify        |        Sign Up for Participation        |        Study Information